# CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

> **NCT02540850** · — · COMPLETED · sponsor: **BioChain (Beijing) Science and Technology, Inc.** · enrollment: 1031 (actual)

## Conditions studied

- Colorectal Cancer
- Adenomatous Polyp of Colon
- Polyps
- Other Disease/Injury
- Other Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02540850
- **Lead sponsor:** BioChain (Beijing) Science and Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 1031 (ACTUAL)
- **Last updated:** 2016-01-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540850, "CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02540850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*